文献速递乳腺MR

浸润性乳腺癌的扩散加权成像:与无远处转移生存期的关系

Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis-free Survival.
PubMed 文献 · Radiology · 2019-03-12

研究纳入258例新诊断浸润性乳腺癌女性,术前MRI扩散加权成像测量平均、最小、最大ADC并计算ADC差值,回顾性分析显示ADC差值较高与无远处转移生存期较差相关(HR 4.5)。

要点

  • ADC差值>0.698×10-3 mm2/sec与无远处转移生存期较差相关,HR 4.5。
  • 有远处转移者ADC差值均值0.743×10-3 mm2/sec,高于无转移者的0.566×10-3 mm2/sec。
  • 腋窝淋巴结转移(HR 3.3)和雌激素受体阴性(HR 2.6)也与无远处转移生存期较差相关。

核心结论

  • 扩散加权成像上较高的表观扩散系数差值值与浸润性乳腺癌女性较差的无远处转移生存期相关。

研究设计与样本

  • 回顾性分析258例新诊断浸润性乳腺癌女性,2013至2014年间行术前MRI扩散加权成像,由两名对临床信息不知情的放射科医师测量病灶平均、最小和最大ADC并计算ADC差值。

关键影像表现/征象

  • 有远处转移者ADC差值均值0.743×10-3 mm2/sec,无远处转移者均值0.566×10-3 mm2/sec,前者较高(P < .001)。

诊断标准与关键数值

  • ADC差值>0.698×10-3 mm2/sec与较差无远处转移生存期相关(HR 4.5;95%CI:2.0,10.0;P < .001)。
  • 腋窝淋巴结转移与较差无远处转移生存期相关(HR 3.3;95%CI:1.2,9.3;P = .02)。
  • 雌激素受体阴性与较差无远处转移生存期相关(HR 2.6;95%CI:1.2,5.7;P = .02)。

临床应用与阅片要点

  • 在术前乳腺MRI扩散加权成像中可测量病灶平均、最小和最大ADC并计算ADC差值以评估瘤内异质性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Combined minimum apparent diffusion coefficient (ADC) and ADC difference value may improve the diagnostic performance of breast diffusion-weighted imaging (DWI) compared with mean ADC. Purpose To investigate whether ADC parameters at DWI are associated with distant metastasis-free survival in women with invasive breast cancer. Materials and Methods Between 2013 and 2014, 258 consecutive women (mean age ± standard deviation, 50.9 years ± 10.5; age range, 23-85 years) with newly diagnosed invasive breast cancer who underwent preoperative MRI with DWI were evaluated. All DWI examinations were retrospectively reviewed by two radiologists blinded to clinical information. The mean, minimum, and maximum ADCs were measured by manually placing regions of interest within the lesions, and the ADC difference value (the difference between minimum and maximum ADCs) was calculated to evaluate intratumoral heterogeneity. Cox proportional hazards models were used to determine the associations between ADC parameters and distant metastasis-free survival after adjustment for clinical-pathologic factors. Results In 25 of the 258 women (9.7%), distant metastasis developed at a median follow-up of 51 months. The ADC difference value was higher in women with distant metastasis than in those without distant metastasis (mean, 0.743 × 10-3 mm2/sec vs 0.566 × 10-3 mm2/sec, respectively; P < .001). Multivariable Cox proportional hazards analysis showed that a higher ADC difference value (>0.698 × 10-3 mm2/sec) (hazard ratio [HR], 4.5; 95% confidence interval [CI]: 2.0, 10.0; P < .001), presence of axillary node metastasis (HR, 3.3; 95% CI: 1.2, 9.3; P = .02), and estrogen receptor negativity (HR, 2.6; 95% CI: 1.2, 5.7; P = .02) were associated with poorer distant metastasis-free survival. Conclusion A higher apparent diffusion coefficient difference value at diffusion-weighted imaging is associated with poorer distant metastasis-free survival of women with invasive breast cancer. © RSNA, 2019 See also the editorial by Taourel in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kim JY, Kim JJ, Hwangbo L, et al. Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis-free Survival. Radiology. 2019. PMID: 30860453. doi:10.1148/radiol.2019181706

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。